Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

A Study of Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancy Receiving Multicycle Chemotherapy

NCT00118638 ·Status: COMPLETED ·Phase: PHASE3

Chemotherapy Related Anemia

NCT00035607 ·Status: COMPLETED ·Phase: PHASE2

Anemia in Patients With a Non-Myeloid Malignancy

NCT00038064 ·Status: COMPLETED ·Phase: PHASE3

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

NCT00416624 ·Status: COMPLETED ·Phase: PHASE2

Treatment for Patients With Non-Myeloid Malignancies Receiving Chemotherapy

NCT00111137 ·Status: COMPLETED ·Phase: PHASE3

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

NCT00091858 ·Status: COMPLETED ·Phase: PHASE3

Chemotherapy Related Anemia in Patients With Non-Myeloid Malignancies

NCT00036023 ·Status: COMPLETED ·Phase: PHASE2

Flexibility: A Study to Assess the Impact of Darbepoetin Alfa in Subjects withNon-Myeloid Malignancies With Anemia Due to Chemotherapy

NCT00144131 ·Status: COMPLETED ·Phase: PHASE2

A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study

NCT00115167 ·Status: COMPLETED ·Phase: PHASE3

Darbepoetin Alfa With or Without Intravenous (IV) Iron

NCT00401544 ·Status: COMPLETED ·Phase: PHASE2

Darbepoetin Alfa and Anemia of Cancer

NCT00989092 ·Status: TERMINATED ·Phase: PHASE2

Fractionated Dosing Study: Study to Evaluate Darbepoetin Alfa for the Treatment of Anemia in Subjects With Non-Myeloid Malignancies

NCT00239239 ·Status: COMPLETED ·Phase: PHASE2

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

NCT00858364 ·Status: TERMINATED ·Phase: PHASE3

Treatment for Patients Suffering From Anemia Due to Chemotherapy

NCT00120692 ·Status: COMPLETED ·Phase: PHASE2

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

NCT00270127 ·Status: COMPLETED ·Phase: PHASE3

Evaluation of Iron Supplementation During Darbepoetin Alfa Treatment in Prophylaxis of Severe Anaemia Chemo-Induced

NCT00210002 ·Status: TERMINATED ·Phase: PHASE2

Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy

NCT00083486 ·Status: TERMINATED ·Phase: PHASE3

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

NCT00095277 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

NCT00283465 ·Status: COMPLETED ·Phase: PHASE4

A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia

NCT01394991 ·Status: COMPLETED ·Phase: PHASE4

Treatment for Patients With Non-Small Cell Lung Cancer Who Developed Anemia Due to Chemotherapy

NCT00120679 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

NCT00216541 ·Status: COMPLETED ·Phase: PHASE4

Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia

NCT00315484 ·Status: COMPLETED ·Phase: PHASE4

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

NCT00661999 ·Status: COMPLETED ·Phase: PHASE3

A Web-based Study of Quality of Life Benefits Associated Aranesp in Anemic Patients With Cancer

NCT00153868 ·Status: COMPLETED ·Phase: PHASE4